AKT1 and prostate cancer: ILK in complex with RICTOR phosphorylates the Ser473 residue of AKT in MDA-MB-231 and MDA-MB-468 breast cancer cells and PC3 prostate cancer cells, where it promotes cell survival and invasion independent of mTORC2 [19,20].